Insulin sensitizer in prediabetes: a clinical study with DLBS3233, a combined bioactive fraction of Cinnamomum burmanii and Lagerstroemia speciosa

References

• BarrEIZimmetPZWelbornTARisk of cardiovascular and all-cause mortality in individual with diabetes mellitus, impaired fasting glucose and impaired glucose tolerance: The Australian Diabetes, Obesity, and Lifestyle Study (Aus Diab)Circulation200710126822689
   Google Scholar
• American Diabetes AssociationDiagnosis and classification of diabetes mellitusDiabetes Care201437Suppl 1S81S9024357215
   PubMed Web of Science ®Google Scholar
• MatfinGPratleyREAdvances in the treatment of prediabetesTher Adv Endocrinol Metab2010151423148144
   PubMedGoogle Scholar
• DeFronzoRAAbdul-GhaniMAPreservation of β-cell function: the key to diabetes preventionJ Clin Endocrinol Metab2011962354236621697254
   PubMed Web of Science ®Google Scholar
• ManafAManagement of prediabetesProceedings of Scientific Conference XI of Internal MedicinePadangDepartment of Internal Medicine, Andalas University2009116
   Google Scholar
• ShinJALeeJHKimHSChoiYHChoJHYoonKHPrevention of diabetes: a strategic approach for individual patientsDiabetes Metab Res Rev201228Suppl 2798423280871
   PubMedGoogle Scholar
• MoutzouriETsimihodimosVRizosEElisafMPrediabetes: to treat or not to treat?Eur J Pharmacol20116721–391922020287
   PubMed Web of Science ®Google Scholar
• Abdul-GhaniMATripathyDDeFronzoRAContribution of β-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucoseDiabetes Care2006291130113916644654
   PubMed Web of Science ®Google Scholar
• DeFronzoRFerranniniEInsulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and athero-sclerotic cardiovascular diseaseDiabetes Care1991141731942044434
   PubMed Web of Science ®Google Scholar
• WajchenbergBLβ-Cell failure in diabetes and preservation by clinical treatmentEndocr Rev20082818721817353295
   PubMed Web of Science ®Google Scholar
• TuomilehtoJLindströmJErikssonJGPrevention of type-2-diabetes mellitus by changes in lifestyle among subjects with impaired glucose toleranceN Engl J Med20013441343135011333990
   PubMed Web of Science ®Google Scholar
• KitabchiAETemprosaMKnowlerWCRole of insulin secretion and sensitivity in the evolution of type-2-diabetes in the Diabetes Prevention Program. Effects of lifestyle intervention and metforminDiabetes2005542404241416046308
   PubMed Web of Science ®Google Scholar
• RamachandranASnehalathaCMarySfor the Indian Diabetes Prevention Programme (IDPP)The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type-2-diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1)Diabetologia20064928929716391903
   PubMed Web of Science ®Google Scholar
• KnowlerWCFowlerSEHammanRFDiabetes Prevention Program Research Group10-Year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes StudyLancet20093741677168619878986
   PubMed Web of Science ®Google Scholar
• ErratumLancet20093742054
   Web of Science ®Google Scholar
• PhungOJBakerWLTongbramVBhardwajAColemanCIOral antidiabetic drugs and regression from prediabetes to normoglycemia: a meta-analysisAnn Pharmacother20124646947622474136
   PubMed Web of Science ®Google Scholar
• ChiassonJLJosseRGGomisRHanefeldMKarasikALaaksoMfor the STOP-NIDDM Trial Research GroupAcarbose for prevention of type-2-diabetes mellitus: the STOP-NIDDM randomized trialLancet20023592072207712086760
   PubMed Web of Science ®Google Scholar
• RamachandranASnehalathaCMarySMukeshBBhaskarADVijayVThe Indian Diabetes Prevention Programmme shows that lifestyle modification and metformin prevent type-2-diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1)Diabetologia20064928929716391903
   PubMed Web of Science ®Google Scholar
• DeFronzoRATripathyDSchwenkeDCfor the ACT NOW StudyPioglitazone for diabetes prevention in impaired glucose toleranceN Engl J Med2011364121104111521428766
   PubMed Web of Science ®Google Scholar
• ErratumN Engl J Med2011365189
   Google Scholar
• ArmatoJDeFronzoRAAbdul-GhaniMRubyRSuccessful treatment of prediabetes in clinical practice: targeting insulin resistance and β-cell dysfunctionEndocr Pract20121834235022068250
   PubMed Web of Science ®Google Scholar
• TandrasasmitaOMWulanDDNailufarFSinambelaJTjandrawinataRRGlucose-lowering effect of DLBS3233 is mediated through phosphorylation of tyrosine and upregulation of PPAR-γ and GLUT-4 expressionInt J Gen Med2011434535721674027
   PubMedGoogle Scholar
• NailufarFTandrasasmitaOMTjandrawinataRRDLBS3233 increases glucose uptake by mediating upregulation of PPAR-γ and PPAR-δ expressionBiomed Prev Nutr201117178
   Google Scholar
• TjandrawinataRRSuastikaKNofiarnyDDLBS3233 extract, a novel insulin sensitizer with negligible risk of hypoglycemia: a phase-I studyInt J Diabetes Metab2011211320
   Google Scholar
• SuastikaKSaraswatiRDwipayanaPNugrahiniNETjandrawinataRRA preliminary study of DLBS3233, a bioactive extract of Lagerstroemia speciosa and Cinnamomum burmanii, in newly diagnosed type-2-diabetesStudy reportDenpasarDepartment of Internal Medicine, University of Udayana2011
   Google Scholar
• BonoraETargherGAlbericheMHomeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivityDiabetes Care200023576310857969
   PubMed Web of Science ®Google Scholar
• UtzschneiderKMPrigeonRLFaulenbachMVOral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levelsDiabetes Care20093233534118957530
   PubMed Web of Science ®Google Scholar
• StumvollMVan HaeftenTWFritscheAGerichAOral glucose tolerance test indexes for insulin sensitivity and secretion based on various availabilities of sampling timesDiabetes Care20012479679711315860
   PubMed Web of Science ®Google Scholar
• StumvollMMitrakouAPimentaWUse of the oral glucose tolerance test to assess insulin release and insulin sensitivityDiabetes Care20002329530110868854
   PubMed Web of Science ®Google Scholar
• Diabetes Prevention Program Research GroupThe prevalence of retinopathy in impaired glucose tolerance and recent-onset diabetes in the Diabetes Prevention ProgramDiabetes Med200724137144
   PubMed Web of Science ®Google Scholar
• ZieglerDRathmannWDickhausTMeisingerCMielckAPrevalence of polyneuropathy in pre-diabetes and diabetes is associated with abdominal obesity and macroangiopathy: the MONICA/KORA Augsburg Surveys S2 and S3Diabetes Care20083146446918039804
   PubMed Web of Science ®Google Scholar
• KahnSEThe relative contributions of insulin resistance and beta cell dysfunction to the pathophysiology of type 2 diabetesDiabetologia20034631912637977
   PubMed Web of Science ®Google Scholar
• FerranniniEGastaldelliAMiyazakiYMatsudaMMariADe-FronzoRABeta-cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysisJ Clin Endocrinol Metab20059049350015483086
   PubMed Web of Science ®Google Scholar
• GastaldelliAFerranniniEMiyazakiYMatsudaMDeFronzoRABeta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) studyDiabetologia200447313914666364
   PubMed Web of Science ®Google Scholar
• GuldstrandMAhrénBAdamsonUImproved b-cell function after standardized weight reduction in severely obese subjectsAm J Physiol Endocrinol Metab2003284E557E56512556352
   PubMed Web of Science ®Google Scholar
• BergmanRNIderYZBowdenCRCobelliCQuantitative estimation of insulin sensitivityAm J Physiol Endocrinol Metab1979236E667E677
   PubMed Web of Science ®Google Scholar
• KahnSEPrigeonRLMcCullochDKQuantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic functionDiabetes199342166316728405710
   PubMed Web of Science ®Google Scholar
• AhrenBPaciniGImportance of quantifying insulin secretion in relation to insulin sensitivity to accurately assess beta cell function in clinical studiesEur J Endocrinol20041509710414763905
   PubMed Web of Science ®Google Scholar
• McAuleyKAWilliamsSMMannJIIntensive lifestyle changes are necessary to improve insulin sensitivity: a randomized controlled trialDiabetes Care20022544545211874928
   PubMed Web of Science ®Google Scholar
• FerranniniENataliACapaldoBLehtovirtaMJacobSYki-JärvinenHInsulin resistance, hyperinsulinemia, and blood pressure: role of age and obesity. European Group for the Study of Insulin Resistance (EGIR)Hypertension199730114411499369268
   PubMed Web of Science ®Google Scholar
• RajiASeelyEWBekinsSAWilliamsGHSimonsonDCRosiglitazone improves insulin sensitivity and lowers blood pressure in hypertensive patientsDiabetes Care20032617217812502676
   PubMed Web of Science ®Google Scholar
• LandinKTengbornLSmithUTreating insulin resistance in hypertension with metformin reduces both blood pressure and metabolic risk factorsJ Intern Med19912291811871900072
   PubMed Web of Science ®Google Scholar